• Nenhum resultado encontrado

Relevance of hMLH1 -93G>A, 655A>G and 1151T>A polymorphisms with colorectal cancer susceptibility: a meta-analysis based on 38 case-control studies

N/A
N/A
Protected

Academic year: 2019

Share "Relevance of hMLH1 -93G>A, 655A>G and 1151T>A polymorphisms with colorectal cancer susceptibility: a meta-analysis based on 38 case-control studies"

Copied!
10
0
0

Texto

Loading

Imagem

TABLE 1: MAIN CHARACTERISTICS OF STUDIES INCLUDED IN THIS META-ANALYSIS.
TABLE 2. THE META-ANALYSIS OF HMLH1 -93G>A (RS1800734) POLYMORPHISMS AND CRC RISK.
TABLE 3. THE META-ANALYSIS OF HMLH1 655A>G AND 1151T>A POLYMORPHISMS AND CRC RISK.

Referências

Documentos relacionados

This meta-analysis suggests that the polymorphism rs198977 of KLK2 was associated with susceptibility of prostate cancer in Caucasian and the allele T might increase the risk

between of IL-10 -592A>C polymorphism and increased GC risk among Asians was detected under the allele model (C vs. When all the eligible studies were pooled into the

Conclusions/Significance: This meta-analysis indicates that ADPRT Val762Ala and APE1 Asp148Glu polymorphisms are not associated with increased breast cancer risk.. Citation: Wu B,

Considering the relatively small sample size in each single study might have low power to detect the effect of the polymorphisms on cancer risk and the underlying heterogeneity

individuals, AC haplotype and GC/AG diplotype for the 118A>G and IVS2+691G>C polymorphisms of OPRM1 are associated with better and poorer sleep quality, respectively..

In order to better understand the genetic role of PDE4B for schizophrenia sus- ceptibility, we recapitulated the association of different PDE4B SNPs with schizophrenia risk

With the present meta-analysis of levels I and II evidence prospective control studies, we were able to support our primary hypothesis that there were no differences in the

Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta- analysis.. Cancer